Curcumin-loaded PLGA Nanoparticles Improve Cognition and Neurogenesis in Alzheimer’s - Ai-Peptides

FREE SHIPPING ON ORDERS OVER $100

Research Categories
Research Categories
More
Research Categories

Peptide Sciences Research

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Curcumin-loaded PLGA Nanoparticles Improve Cognition and Neurogenesis in Alzheimer’s

The PLGA-based curcumin treatment for AD uses nanoparticles to transport curcumin to the brain. [1-3] The nanoparticles comprise PLGA, a biocompatible and biodegradable polymer.[5] The nanoparticles are small enough to cross the BBB, which is typically challenging for medications targeting the brain.[5] Once the nanoparticles reach the brain, they release curcumin, reducing neuroinflammation, inhibiting the aggregation of misfolding proteins, and improving neuroprotection and cognition.[1-5] In other words, by decreasing neuroinflammation and inhibiting the development of abnormal proteins, PLGA-based curcumin remedy can slow down or even reverse the advancement of AD.[5-9 Several articles have shown that the PLGA-based curcumin treatment can help in combating other neurodegenerative disorders like Parkinson’s disease (PD) by reducing PD symptoms, apoptosis, and oxidative stress.[12] The PLGA-based curcumin therapy could provide a wide range of benefits in AD patients by decreasing the progression of most of the pathological aspects of the disorder.[5-10] In addition, this therapy overcomes one of the most challenging aspects of AD treatment, which is to cross the BBB.[1] PLGA-based curcumin provides a safe, viable, stable, nontoxic, and efficient way to fight AD progression.[11] Clinical trials for PLGA-based curcumin are ongoing, aiming to study the effectiveness and safety of using this treatment on humans.[10-13] Even though the results are unavailable, the preclinical studies show remarkable results in mice models.[12]

Benefit summary of the nano-based curcumin delivery system (PLGA-based curcumin)

  • Decrease Amyloid beta and tau misfolding, accumulation, and toxicity.
  • Improves memory and cognition in AD models (see Fig. 2).
  • High circulation time in blood and bioavailability
  • Cross the Blood-brain barrier
  • Decreases neuronal cell death.
  • Reduces neuroinflammation dramatically.
  • Enhances neuroprotection and neuroplasticity.
  • Inhibit the activation of cytokines.
  • Promotes the heat shock response.
  • Reduces the immune cell infiltration.

Be the first to know

Receive all the latest information on events, sales, & offers.

Welcome back!

or
Menu
Explore

Search Peptides

Welcome back!

or
0